Correlation Between CodeLab Capital and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CodeLab Capital and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CodeLab Capital and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CodeLab Capital AS and PCI Biotech Holding, you can compare the effects of market volatilities on CodeLab Capital and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CodeLab Capital with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CodeLab Capital and PCI Biotech.

Diversification Opportunities for CodeLab Capital and PCI Biotech

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between CodeLab and PCI is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding CodeLab Capital AS and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and CodeLab Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CodeLab Capital AS are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of CodeLab Capital i.e., CodeLab Capital and PCI Biotech go up and down completely randomly.

Pair Corralation between CodeLab Capital and PCI Biotech

Assuming the 90 days trading horizon CodeLab Capital AS is expected to generate 1.04 times more return on investment than PCI Biotech. However, CodeLab Capital is 1.04 times more volatile than PCI Biotech Holding. It trades about 0.05 of its potential returns per unit of risk. PCI Biotech Holding is currently generating about -0.07 per unit of risk. If you would invest  246.00  in CodeLab Capital AS on November 29, 2025 and sell it today you would earn a total of  19.00  from holding CodeLab Capital AS or generate 7.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.33%
ValuesDaily Returns

CodeLab Capital AS  vs.  PCI Biotech Holding

 Performance 
       Timeline  
CodeLab Capital AS 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CodeLab Capital AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, CodeLab Capital disclosed solid returns over the last few months and may actually be approaching a breakup point.
PCI Biotech Holding 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days PCI Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

CodeLab Capital and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CodeLab Capital and PCI Biotech

The main advantage of trading using opposite CodeLab Capital and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CodeLab Capital position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind CodeLab Capital AS and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals